EQT Completes Share Sale in Galderma

Deal News | Jul 31, 2025 | EQT

EQT, through its affiliate EQT VIII, has completed an accelerated bookbuilding process involving the sale of 17 million shares in Galderma Group AG. This resulted in aggregate gross proceeds of approximately CHF 2.1 billion, out of which EQT received roughly CHF 555 million. The transaction was finalized on July 31, 2025. BNP Paribas, Citigroup Global Markets, Goldman Sachs, Jefferies, Morgan Stanley, and UBS served as the joint global coordinators and joint bookrunners for the sale. EQT is a significant global investment firm that manages assets totaling EUR 266 billion, focusing on Private Capital and Real Assets.

Sectors

  • Private Equity
  • Healthcare
  • Financial Services

Geography

  • Switzerland – Switzerland is relevant as Galderma Group AG is listed on the Swiss stock exchange (SIX: GALD), and the transaction was governed by Swiss financial regulations.
  • Global – EQT is a global investment organization with a presence in Europe, Asia Pacific, and the Americas, managing a diverse portfolio worldwide.

Industry

  • Private Equity – The industry classification is relevant as the article discusses a transaction facilitated by EQT, a well-known private equity firm, involving the sale of shares in Galderma Group AG.
  • Healthcare – Galderma Group AG operates within the healthcare sector, specifically focused on dermatology, making this a relevant industry classification.
  • Financial Services – The involvement of major banks like BNP Paribas, Citigroup Global Markets, and others in the joint bookrunning process categorizes this also under financial services.

Financials

  • CHF 2.1 billion – This is the total gross proceeds resulting from the sale of 17 million shares in Galderma Group AG.
  • CHF 555 million – This is the portion of the proceeds that EQT received from the sale.

Participants

NameRoleTypeDescription
EQTSelling CompanyCompanyEQT is a global investment organization responsible for managing the funds that facilitated the sale of shares in Galderma Group AG.
Galderma Group AGTarget CompanyCompanyGalderma Group AG is a Swiss company in which EQT has sold 17 million shares as part of their investment strategy.
BNP Paribas, Citigroup Global Markets, Goldman Sachs, Jefferies, Morgan Stanley, UBSFinancial Advisors/Joint BookrunnersCompanyThese financial institutions acted as joint global coordinators and joint bookrunners for the share sale.